New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles

Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

FDA's MedWatch Safety Alerts for Consumers: August 2015

Tue, 06 Oct 2015 10:00:00 -0400

FDA is warning consumers about left ventricular assist devices, faulty mammograms, DPP-4 inhibitors, and Picato gel.

'All Natural' Alternatives for Erectile Dysfunction: A Risky Proposition

Thu, 01 Oct 2015 09:00:00 -0400

FDA's testing of many suspect products that promise to enhance sexual performance or treat erectile dysfunction found that some contain undisclosed and potentially harmful drugs.

The Benefits and Risks of Pain Relievers: Q & A on NSAIDs with Sharon Hertz, M.D.

Wed, 23 Sep 2015 00:00:00 -0400

Questions and answers about the benefits and risks of non-steroidal anti-inflammatory drugs (NSAIDs)

5 Ways New FDA Rules Will Make Your Foods Safer

Wed, 09 Sep 2015 08:00:00 -0400

How will you and your family be protected by the new actions FDA is taking to keep your food safe?

Injectable Skin Lightening Products: What You Should Know

Wed, 02 Sep 2015 07:00:00 -0400

Injectable skin lightening products are unapproved, untested drugs that could potentially cause harm, FDA warns. FDA has not approved any injectable drugs for skin whitening or lightening.

Food and Drug Administration--Press Releases

Federal judge issues permanent injunction against South Dakota laser manufacturer

Wed, 07 Oct 2015 13:15:00 -0400

A federal judge in the U.S. District Court for the District of South Dakota yesterday granted the U.S. Food and Drug Administration a permanent injunction against 2035 Inc. and Robert “Larry” Lytle, doing business as QLasers PMA and 2035 PMA.

FDA launches national public education campaign to prevent and reduce tobacco use among multicultural youth

Tue, 06 Oct 2015 09:01:00 -0400

The U.S. Food and Drug Administration today announced the launch of a national public education campaign to prevent and reduce tobacco use among youth who identify with the hip-hop peer crowd ‒ a hard-to-reach group that is frequently exposed to pro-tobacco images and messages. The FDA’s new campaign, "Fresh Empire," is designed to reach the approximately 6 million multicultural youth ages 12–17, specifically African American, Hispanic, and Asian American/Pacific Islander youth, who are open to smoking or are already experimenting with cigarettes.

FDA approves new injectable drug to treat schizophrenia

Tue, 06 Oct 2015 08:29:00 -0400

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.

FDA approves expanded indication for medical device to treat a form of brain cancer

Mon, 05 Oct 2015 17:56:00 -0400

The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer. It is given along with the chemotherapy drug temozolomide (TMZ) following standard treatments that include surgery, chemotherapy, and radiation therapy.

FDA orders duodenoscope manufacturers to conduct postmarket surveillance studies in health care facilities

Mon, 05 Oct 2015 11:09:00 -0400

The U.S. Food and Drug Administration today ordered the three manufacturers of duodenoscopes marketed in the U.S. to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings.